Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Although the atherogenic index of plasma (AIP) based on a single measurement is a known risk factor for cardiovascular disease (CVD), little is known about whether changes in AIP over time are related to incident CVD. We aimed to determine whether AIP trajectory, which reflects homogenous AIP trends for a particular period, is associated with CVD risk.

Methods: Data from 5,843 participants of the Korean Genome and Epidemiology Study (KoGES) were analyzed. The KoGES had been conducted biennially from the baseline survey (2001-2002) to the eighth follow-up survey (2017-2018). The research design specifies the exposure period from baseline to the third follow-up, designates the latent period at the fourth follow-up, and establishes the event accrual period from the fifth to the eighth follow-up. During the exposure period, we identified two trajectories: a decreasing (n = 3,036) and an increasing group (n = 2,807) using latent variable mixture modeling. Information on CVD was collected initially through the self-reporting, followed by in depth person-to-person interview conducted by a well-trained examiner. During the event accrual period, the cumulative incidence rates of CVD between the two AIP trajectory groups were estimated using Kaplan-Meier analysis with the log-rank test. Multiple Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).

Results: The increasing AIP trajectory group had a significantly higher cumulative incidence rate of CVD than the decreasing AIP trajectory group. Compared to the decreasing AIP trajectory group, the increasing AIP trajectory group had a higher risk of incident CVD (HR: 1.31, 95% CI: 1.02-1.69) after adjusting for confounders.

Conclusions: The risk of incident CVD increased when the AIP level showed an increasing trend and remained high over a long period. This suggests that checking and managing the trajectory of the AIP can be a preventive strategy for incident CVD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506251PMC
http://dx.doi.org/10.1186/s12959-023-00542-yDOI Listing

Publication Analysis

Top Keywords

aip trajectory
24
incident cvd
16
trajectory group
16
aip
11
cvd
9
atherogenic plasma
8
korean genome
8
genome epidemiology
8
epidemiology study
8
eighth follow-up
8

Similar Publications

Aiming at the goal of preparing high-quality coatings, this paper reviews the progress on circular arc source structure and magnetic field arc controlling technology in arc ion plating (AIP), with a focus on design characteristics of the different structures and configuration optimization of the corresponding magnetic fields. The circular arc source, due to its simple structure, convenient installation, flexible target combination, high cooling efficiency, and high ionization rate and deposition rate, has shown significant application potential in AIP technology. In terms of magnetic field arc controlling technology, this paper delves into the design progress of various magnetic field configurations, including fixed magnetic fields generated by permanent magnets, dynamic rotating magnetic fields, axially symmetric magnetic fields, rotating transverse magnetic fields, and multi-mode alternating electromagnetic coupling fields.

View Article and Find Full Text PDF

Background And Aims: The atherogenic index of plasma (AIP) has been proposed as a new biomarker for atherosclerosis and cardiovascular diseases. This study aimed to investigate the association between AIP and the incidence and progression of carotid atherosclerosis (CAS).

Methods: We enrolled 528 participants who underwent routine annual health examinations at the Health Management Center of Hunan Provincial People's Hospital for three consecutive years, from January 2019 to December 2021.

View Article and Find Full Text PDF

Background: The impact of dynapenic obesity on the progression of cardiometabolic multimorbidity (CMM) remains poorly understood. This study aimed to explore the association between dynapenic obesity and cardiometabolic diseases (CMD) progression, as well as the mediating roles of C-reactive protein (CRP) and the atherogenic index of plasma (AIP).

Methods: The study included 446,862 UK Biobank participants.

View Article and Find Full Text PDF

Background: Atherogenic indices (AIs) predict metabolic abnormalities, yet their longitudinal patterns and interaction with antipsychotics in schizophrenia-related metabolic syndrome (MetS) remain unclear.

Methods: This longitudinal study composed of 469 MetS-free participants identified AIs trajectories from three follow-up assessments (2019-2021). Group-based trajectory modeling characterized atherogenic index of plasma (AIP), atherogenic coefficient (AC), and Castelli risk index II (CRI-II).

View Article and Find Full Text PDF

Background: For patients with type 2 diabetes (T2D), the triglyceride-glucose (TyG) index, the atherogenic index of plasma (AIP) and the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (NHHR) are recognized as reliable predictors of cardiovascular diseases. However, the association of these predictors with microvascular complications (MVCs) in T2D remains controversial and warrants further investigation.

Methods: Using data from the Action to Control Cardiovascular Risk in Diabetes study, we examined the association of cardiometabolic indices with the risk of incident microvascular outcomes, including diabetic kidney disease (DKD), diabetic neuropathy (DN) and diabetic retinopathy (DR).

View Article and Find Full Text PDF